Tumor necrosis factor-α inhibitors and their effects on cardiovascular risk factorsin patients with rheumatoid arthritis

by O G Lineva, T V Popkova, D S Novikova, E L Nasonov, O G Lineva, T V Popkova, D S Novikova, E L Nasonov
Published 2010-02-01

Impact of rituximab therapy on endothelial function and other markers of atherosclerosisin patients with active rheumatoid arthritis

by Aleksandr Vital'evich Volkov, O G Lineva, K Kh Kuzikyants, G V Lukina, E L Nasonov, Aleksandr Vitalyevich Volkov, O G Lineva, K Kh Kuzikyants, G V Lukina, E L Nasonov
Published 2010-12-01

EFFECT OF RITUXIMAB ON THE BLOOD CHOLESTEROL TRANSPORT SYSTEM IN PATIENTSWITH RHEUMATOID ARTHRITIS

by Tatyana Valentinovna Popkova, D S Novikova, O G Lineva, A A Novikov, E N Aleksandrova, E L Nasonov
Published 2010-08-01

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS

by Elena Nikolayevna Aleksandrova, A S Avdeyeva, G V Lukina, A A Novikov, M V Cherkasova, T V Popkova, O G Lineva, G Kh Kuzikyants, E L Nasonov
Published 2012-02-01

ROLE OF MULTIPLEX CYTOKINE ANALYSIS IN THE EVALUATION OF THE EFFICACY OF RITUXIMAB DURING TREATMENT FOR RHEUMATOID ARTHRITIS

by A. A. Novikov, E. N. Aleksandrova, T. V. Popkova, O. G. Lineva, A. S. Avdeyeva, D. S. Novikova, G. Kh. Kuzikyants, G. V. Lukina, Ya. A. Sigidin, A. V. Karaulov, S. N. Bykovskaya, E. L. Nasonov
Published 2011-06-01